144 related articles for article (PubMed ID: 30684530)
41. Reversal of hypermethylation and reactivation of glutathione S-transferase pi 1 gene by curcumin in breast cancer cell line.
Kumar U; Sharma U; Rathi G
Tumour Biol; 2017 Feb; 39(2):1010428317692258. PubMed ID: 28222671
[TBL] [Abstract][Full Text] [Related]
42. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.
Nohesara S; Ghadirivasfi M; Mostafavi S; Eskandari MR; Ahmadkhaniha H; Thiagalingam S; Abdolmaleky HM
J Psychiatr Res; 2011 Nov; 45(11):1432-8. PubMed ID: 21820670
[TBL] [Abstract][Full Text] [Related]
43. Characterization of two new variants of human catechol O-methyltransferase in vitro.
Li Y; Yang X; van Breemen RB; Bolton JL
Cancer Lett; 2005 Dec; 230(1):81-9. PubMed ID: 16253764
[TBL] [Abstract][Full Text] [Related]
44. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells.
Xie Q; Bai Q; Zou LY; Zhang QY; Zhou Y; Chang H; Yi L; Zhu JD; Mi MT
Genes Chromosomes Cancer; 2014 May; 53(5):422-31. PubMed ID: 24532317
[TBL] [Abstract][Full Text] [Related]
45. Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic Modification.
Su CH; Lin IH; Tzeng TY; Hsieh WT; Hsu MT
PLoS One; 2016; 11(11):e0166090. PubMed ID: 27806114
[TBL] [Abstract][Full Text] [Related]
46. Aberrant promoter methylation may be responsible for the control of CD146 (MCAM) gene expression during breast cancer progression.
Dudzik P; Trojan SE; Ostrowska B; Lasota M; Dulińska-Litewka J; Laidler P; Kocemba-Pilarczyk KA
Acta Biochim Pol; 2019 Dec; 66(4):619-625. PubMed ID: 31826047
[TBL] [Abstract][Full Text] [Related]
47. Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme.
Tenhunen J; Salminen M; Jalanko A; Ukkonen S; Ulmanen I
DNA Cell Biol; 1993 Apr; 12(3):253-63. PubMed ID: 8466648
[TBL] [Abstract][Full Text] [Related]
48. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
Chang YW; Singh KP
PLoS One; 2017; 12(3):e0174227. PubMed ID: 28323900
[TBL] [Abstract][Full Text] [Related]
49. Assessment of cellular estrogenic activity based on estrogen receptor-mediated reduction of soluble-form catechol-O-methyltransferase (COMT) expression in an ELISA-based system.
Ho PW; Tse ZH; Liu HF; Lu S; Ho JW; Kung MH; Ramsden DB; Ho SL
PLoS One; 2013; 8(9):e74065. PubMed ID: 24040167
[TBL] [Abstract][Full Text] [Related]
50. Bisphenol A-associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver.
Nahar MS; Kim JH; Sartor MA; Dolinoy DC
Environ Mol Mutagen; 2014 Apr; 55(3):184-95. PubMed ID: 24214726
[TBL] [Abstract][Full Text] [Related]
51. Nuclear localization of catechol-O-methyltransferase in neoplastic and nonneoplastic mammary epithelial cells.
Weisz J; Fritz-Wolz G; Gestl S; Clawson GA; Creveling CR; Liehr JG; Dabbs D
Am J Pathol; 2000 Jun; 156(6):1841-8. PubMed ID: 10854207
[TBL] [Abstract][Full Text] [Related]
52. Sulforaphane epigenetically demethylates the CpG sites of the miR-9-3 promoter and reactivates miR-9-3 expression in human lung cancer A549 cells.
Gao L; Cheng D; Yang J; Wu R; Li W; Kong AN
J Nutr Biochem; 2018 Jun; 56():109-115. PubMed ID: 29525530
[TBL] [Abstract][Full Text] [Related]
53. Secreted phospholipases A₂are differentially expressed and epigenetically silenced in human breast cancer cells.
Brglez V; Pucer A; Pungerčar J; Lambeau G; Petan T
Biochem Biophys Res Commun; 2014 Feb; 445(1):230-5. PubMed ID: 24508801
[TBL] [Abstract][Full Text] [Related]
54. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA
J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113
[TBL] [Abstract][Full Text] [Related]
55. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
56. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
Fleury L; Gerus M; Lavigne AC; Richard-Foy H; Bystricky K
Oncogene; 2008 Jul; 27(29):4075-85. PubMed ID: 18317449
[TBL] [Abstract][Full Text] [Related]
57. MB-COMT promoter DNA methylation is associated with working-memory processing in schizophrenia patients and healthy controls.
Walton E; Liu J; Hass J; White T; Scholz M; Roessner V; Gollub R; Calhoun VD; Ehrlich S
Epigenetics; 2014 Aug; 9(8):1101-7. PubMed ID: 24837210
[TBL] [Abstract][Full Text] [Related]
58. 17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.
Butterworth M; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Jun; 9(4):793-9. PubMed ID: 8831825
[TBL] [Abstract][Full Text] [Related]
59. Resveratrol up-regulates ATP2A3 gene expression in breast cancer cell lines through epigenetic mechanisms.
Izquierdo-Torres E; Hernández-Oliveras A; Meneses-Morales I; Rodríguez G; Fuentes-García G; Zarain-Herzberg Á
Int J Biochem Cell Biol; 2019 Aug; 113():37-47. PubMed ID: 31173924
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer cells.
Hitchler MJ; Wikainapakul K; Yu L; Powers K; Attatippaholkun W; Domann FE
Epigenetics; 2006; 1(4):163-71. PubMed ID: 17965603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
